Research
Cohen Fund bolsters Siciliano’s memory research
Sep. 24, 2020—Cody Siciliano, PhD, assistant professor of Pharmacology in the Vanderbilt University School of Medicine, has been selected to receive a one-year, $100,000 research award from the Stanley Cohen Innovation Fund to support his studies of the neural substrates of memory.
Vanderbilt computer scientists awarded NSF grant to restructure research’s road to the public
Sep. 22, 2020—Vanderbilt researchers have been awarded a National Science Foundation Convergence Accelerator 2020 Cohort Phase 1 grant to create a standardized platform that will streamline the development, testing and dissemination of technology that can improve human health. The nine-month project, “Scalable, Traceable AI for Imaging Translation: Innovation to Implementation for Accelerated Impact (STRAIT I3),” looks specifically...
Vanderbilt leads data effort for early prediction of pathogen outbreaks
Sep. 22, 2020—NSF Convergence grant dovetails with Microsoft PREMONITION program expansion Vanderbilt engineers are leading the academic component of a massive Microsoft project that combines robotics, genomics, big data collection—and mosquitos—to monitor the environment and detect potential pandemics and other threats before they cause widespread outbreaks. Microsoft announced today expansion of its PREMONITION program and a large-scale...
Rational vaccine design
Sep. 22, 2020—Understanding immunity generated by smallpox vaccine may hold lessons for COVID-19 vaccine development.
Throwing weight around on the internet
Sep. 21, 2020—What users mention in online weight loss forum tracks with how much weight they lose.
Probing pathogen antibiotic resistance
Sep. 17, 2020—Understanding how bacteria evolve resistance to antibiotics and host stresses could guide the development of more effective antimicrobial therapeutics.
New predictors of prostate cancer risk
Sep. 17, 2020—An international group of researchers including Vanderbilt epidemiologists has identified new DNA methylation biomarkers associated with prostate cancer risk.
Award supports integration of genomic data, electronic health records
Sep. 10, 2020—Eric Gamazon, PhD, assistant professor of Medicine, has been awarded a $1.5 million grant from the National Human Genome Research Institute, part of the National Institutes of Health (NIH), to develop novel computational tools that integrate functional genomic data and electronic health records.
VUMC to lay groundwork for Tennessee’s first federally funded Alzheimer’s Disease Research Center
Sep. 10, 2020—Angela Jefferson, PhD, professor of Neurology and director of the Vanderbilt Memory and Alzheimer’s Center, has been awarded a $3.7 million, three-year grant from the National Institute on Aging (NIA) to support establishment of a prospective NIA-funded Alzheimer’s Disease Research Center (ADRC) at Vanderbilt University Medical Center.
Fibroids and birth outcomes
Sep. 8, 2020—Women with three or more uterine fibroids — non-cancerous growths — during pregnancy are more likely to have infants with reduced birthweight and may need additional surveillance.
Possible key to COVID-19 infectivity
Sep. 7, 2020—New findings demonstrate how genetic variations in the receptor that binds SARS-CoV-2 impact virus recognition and infectivity and offer insights to COVID-19 susceptibility and treatment.
New clue to Alzheimer’s disease
Sep. 3, 2020—Combining studies of genetically diverse mouse populations and human data led to the identification of a gene associated with cognitive decline and brain changes in Alzheimer’s disease.